Harbingers of Dementia-or Not?

Nov 6, 2017

Hypertension, loss of sense of smell, personality changes: which can predict dementia?

Related Videos

Related Content

The Week in Review: May 8-12

What Will the Future of Alzheimer Disease Treatment Look Like?

Researchers Explore Effects of rTMS on Patients With Geriatric Depression

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

Progress Made Toward the Approval of Treatment of Agitation Associated With Alzheimer Dementia

April 17th 2023

From the Pages of Psychiatric Times: March 2023

March 31st 2023

The Week in Review: May 8-12

What Will the Future of Alzheimer Disease Treatment Look Like?

Researchers Explore Effects of rTMS on Patients With Geriatric Depression

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

Progress Made Toward the Approval of Treatment of Agitation Associated With Alzheimer Dementia

April 17th 2023

From the Pages of Psychiatric Times: March 2023

March 31st 2023

The Week in Review: May 8-12

What Will the Future of Alzheimer Disease Treatment Look Like?

Researchers Explore Effects of rTMS on Patients With Geriatric Depression

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

Progress Made Toward the Approval of Treatment of Agitation Associated With Alzheimer Dementia

April 17th 2023

From the Pages of Psychiatric Times: March 2023

March 31st 2023

Related Content

From the relationship between social media and self-diagnosis to the FDA approval of the first treatment for agitation associated with Alzheimer disease dementia, here are highlights from the week in Psychiatric Times.

The Week in Review: May 8-12

What Will the Future of Alzheimer Disease Treatment Look Like?

What Will the Future of Alzheimer Disease Treatment Look Like?

Study investigates connections between rTMS and factors including depression and cognitive performance.

Researchers Explore Effects of rTMS on Patients With Geriatric Depression

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

If approved, the drug will be the first FDA-approved treatment for agitation associated with Alzheimer dementia in the United States.

Progress Made Toward the Approval of Treatment of Agitation Associated With Alzheimer Dementia

April 17th 2023

The experts weighed in on a wide variety of psychiatric issues for the March 2023 issue of Psychiatric Times.

From the Pages of Psychiatric Times: March 2023

March 31st 2023

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.